In addition, type-1 gene mutations (FLT3, PTPN11, NRAS NPM1, IDH1, IDH2, and WT1) were acquired during MDS progression to AML and are considered to be associated with faster leukemic transformation. The gene discussed is IDH2; the disease is myelodysplastic syndrome.